Mwandishi:
Mhariri:
ULY CLINIC
Dkt. Benjamin L, MD
17 Machi 2021, 20:01:51
Ectasy na ujauzito
ONYO: Usitumie dawa yoyote bila ushauri wa daktari. Dawa zinaweza kuleta madhara mwilini na pia matumizi ya baadhi ya dawa pasipo ushauri na vipimo husababisha vimelea kuwa sugu dhidi ya dawa hiyo.
ULY clinic inakushauri kuwasiliana na daktari wako unapotaka kuchukua maamuzi yoyote yanayohusu afya yako.
Wasiliana na daktari/Mfamasia wa ULY clinic kwa ushauri na Tiba au kuandikiwa dawa kwa kupiga simu au Kubonyeza Pata tiba chini ya tovuti hii.
Imeboreshwa,
1 Julai 2023, 17:21:36
Rejea za mada hii
1. Baggott M, Heifets B, Jones RT, Mendelson J, Sferios E, Zehnder J. Chemical analysis of ecstasy pills. JAMA 2000;284:2190.
2. Plessinger MA. Prenatal exposure to amphetamines. Risks and adverse outcomes in pregnancy. Obstet Gynecol Clin North Am 1998;25:119–38.
3. St Omer VEV, Ali SF, Holson RR, Duhart HM, Scalzo FM, Slikker W Jr. Behavioral and neurochemical effects of prenatal methylenedioxymethamphetamine (MDMA) exposure in rats. Neurotoxicol Teratol 1991;13:13–20.
4. Colado MI, O’Shea E, Granados R, Misra A, Murray TK, Green AR. A study of the neurotoxic effect of MDMA (‘ecstasy’) on 5-HT neurones in the brains of mothers and neonates following administration of the drug during pregnancy. Br J Pharmacol 1997;121:827–33.
5. van Tonningen MR, Garbis H, Reuvers M. Ecstasy exposure during pregnancy (abstract). Teratology 1998;58:33A.
6. McElhatton PR, Bateman DN, Evans C, Pughe KR, Thomas SHL. Congenital anomalies after prenatal ecstasy exposure. Lancet 1999;354:1441–2.
7. Committee on Drugs, American Academy of Pediatrics. The transfer of drugs and other chemicals into human milk. Pediatrics 2001;108:776–89.